The possibility of bullous pemphigoid was also unlikely, given that the blister was located on "a single distal extremity," the researchers said.

Which treatments work best for bullous pemphigoid (a rare, itchy skin disease that causes blisters)? Key messages • A cream, containing topical steroid clobetasol propionate, applied on the entire ...

Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after ...

Elderly patients may have especially harmful reactions to systemic glucocorficoid treatment or prednisolone, including cataracts, osteoporosis, and diabetes (Fitzpatrick et al., 2008).

Diagnosis of Bullous Pemphigoid Direct immunofluorescence on a sample of perilesional skin will show linear deposits of IgG on the basement membrane of the epidermis in most if not all patients ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

The approval of Dupixent for bullous pemphigoid is expected to offer new hope to patients who have previously faced limited treatment options. With the potential to effectively manage symptoms and ...

Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid (BP), a condition that predominantly ...

More than 8 million people worldwide live with type 1 diabetes, a lifelong condition marked by the loss of insulin-producing beta cells.

Patients with moderate-to-severe bullous pemphigoid were randomly assigned to receive Dupixent 300 mg (53 individuals) or placebo (53 individuals) added to standard-of-care oral corticosteroids. At 36 ...